Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2014

Oct 3, 2014

30237_dirs_2014-10-03_4a4b9b03-3917-43c8-b722-335ae4b0f6ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LIPOSCIENCE INC (LPDX)
CIK: 0001168197
Period of Report: 2014-09-24

Reporting Person: LABORATORY CORP OF AMERICA HOLDINGS (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Indirect

Footnotes

F1: The Reporting Person is filing this Form 3 solely due to entering into certain Voting Agreements by and among the Reporting Person and certain stockholders of LipoScience, Inc. (the "Voting Agreements"), pursuant to which the Reporting Person was granted an irrevocable proxy to vote 2,709,300 shares of the Issuer's common stock held by such stockholders (the "Issuer Common Stock"). The Voting Agreements were entered into in connection with the Agreement and Plan of Merger, dated September 24, 2014, among the Reporting Person, Bear Acquisition Corp. and the Issuer (the "Merger Agreement"). The Reporting Person disclaims beneficial ownership of the shares of the Issuer Common Stock for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the filing of this Form 3 shall not be an admission that the Reporting Person is the beneficial owner for such purposes.

F2: For additional information regarding the Voting Agreements and the Merger Agreement, see the Schedule 13D filed by the Reporting Person with the U.S. Securities and Exchange Commission on October 3, 2014.